BIOMARKER:

CCND1 amplification

Entrez ID:

Related biomarkers:

‹

›

CCND1 amplification CCND1 amplification	Melanoma Melanoma	sorafenib Sensitive: B - Late Trials
CCND1 amplification CCND1 amplification	Estrogen Receptor Positive Breast Cancer Estrogen Receptor Positive Breast Cancer	palbociclib Resistant: C3 – Early Trials
CCND1 amplification CCND1 amplification	Solid Tumor Solid Tumor	Immunotherapy Resistant: C3 – Early Trials
CCND1 amplification CCND1 amplification	Breast Cancer Breast Cancer	Aromatase inhibitor Resistant: C3 – Early Trials
CCND1 amplification CCND1 amplification	Melanoma Melanoma	ribociclib Sensitive: C3 – Early Trials
CCND1 amplification CCND1 amplification	Lung Non-Small Cell Squamous Cancer Lung Non-Small Cell Squamous Cancer	palbociclib Sensitive: C3 – Early Trials
CCND1 amplification CCND1 amplification	Melanoma Melanoma	toripalimab Resistant: C3 – Early Trials
CCND1 amplification CCND1 amplification	Head and Neck Cancer Head and Neck Cancer	cetuximab + palbociclib Sensitive: C3 – Early Trials
CCND1 amplification CCND1 amplification	Breast Cancer Breast Cancer	lapatinib Sensitive: D – Preclinical